- IN₹137.16bn
- IN₹123.28bn
- IN₹25.90bn
- 78
- 16
- 79
- 62
Annual income statement for Indegene, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,429 | 9,663 | 16,646 | 23,061 | 25,896 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,617 | 7,503 | 14,580 | 19,697 | 21,465 |
Operating Profit | 812 | 2,160 | 2,066 | 3,364 | 4,431 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 758 | 2,315 | 2,265 | 3,630 | 4,586 |
Provision for Income Taxes | |||||
Net Income After Taxes | 497 | 1,857 | 1,628 | 2,661 | 3,367 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -63 | 1,494 | 1,648 | 2,661 | 3,367 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -63 | 1,494 | 1,648 | 2,661 | 3,367 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.51 | 7.39 | 8.3 | 11.1 | 14.9 |
Dividends per Share |